News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
712,214 Results
Type
Article (42527)
Company Profile (439)
Press Release (669248)
Section
Business (209085)
Career Advice (2078)
Deals (36043)
Drug Delivery (103)
Drug Development (83564)
Employer Resources (173)
FDA (16437)
Job Trends (15118)
News (353245)
Policy (33118)
Tag
2024 BioCapital Digital (10)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (8)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (6)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (8)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2642)
Accelerated approval (3)
Adcomms (24)
Allergies (80)
Alliances (50987)
ALS (79)
Alzheimer's disease (1376)
Antibody-drug conjugate (ADC) (113)
Approvals (16407)
Artificial intelligence (228)
Autoimmune disease (12)
Automation (14)
Bankruptcy (367)
Best Places to Work (11877)
BIOSECURE Act (18)
Biosimilars (94)
Biotechnology (333)
Bladder cancer (55)
Brain cancer (24)
Breast cancer (244)
Cancer (1873)
Cardiovascular disease (148)
Career advice (1735)
Career pathing (29)
CAR-T (139)
Cell therapy (400)
Cervical cancer (13)
Clinical research (67281)
Collaboration (750)
Compensation (421)
Complete response letters (23)
COVID-19 (2639)
CRISPR (38)
C-suite (196)
Cystic fibrosis (102)
Data (1789)
Decentralized trials (2)
Denatured (25)
Depression (43)
Diabetes (234)
Diagnostics (6394)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (112)
Drug pricing (103)
Drug shortages (26)
Duchenne muscular dystrophy (74)
Earnings (87055)
Editorial (35)
Employer branding (21)
Employer resources (150)
Events (115059)
Executive appointments (620)
FDA (17445)
Featured Employer (58)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (667)
Gene editing (98)
Generative AI (19)
Gene therapy (282)
GLP-1 (704)
Government (4476)
Grass and pollen (4)
Guidances (46)
Healthcare (19252)
Huntington's disease (23)
IgA nephropathy (22)
Immunology and inflammation (102)
Indications (24)
Infectious disease (2762)
Inflammatory bowel disease (135)
Inflation Reduction Act (11)
Influenza (44)
Intellectual property (73)
Interviews (327)
IPO (16771)
IRA (43)
Job creations (3705)
Job search strategy (1470)
Kidney cancer (9)
Labor market (29)
Layoffs (472)
Leadership (16)
Legal (7978)
Liver cancer (72)
Lung cancer (271)
Lymphoma (124)
Machine learning (2)
Management (61)
Manufacturing (260)
MASH (60)
Medical device (13504)
Medtech (13509)
Mergers & acquisitions (19689)
Metabolic disorders (623)
Multiple sclerosis (62)
NASH (19)
Neurodegenerative disease (82)
Neuropsychiatric disorders (29)
Neuroscience (1843)
NextGen: Class of 2025 (6807)
Non-profit (4574)
Northern California (2275)
Now hiring (36)
Obesity (343)
Opinion (220)
Ovarian cancer (63)
Pain (74)
Pancreatic cancer (71)
Parkinson's disease (125)
Partnered (17)
Patents (186)
Patient recruitment (83)
Peanut (46)
People (58573)
Pharmaceutical (86)
Pharmacy benefit managers (19)
Phase I (21128)
Phase II (29696)
Phase III (21953)
Pipeline (846)
Podcasts (68)
Policy (109)
Postmarket research (2602)
Preclinical (8997)
Press Release (67)
Prostate cancer (89)
Psychedelics (37)
Radiopharmaceuticals (258)
Rare diseases (364)
Real estate (6014)
Recruiting (66)
Regulatory (22547)
Reports (43)
Research institute (2432)
Resumes & cover letters (356)
Rett syndrome (3)
RNA editing (2)
RSV (37)
Schizophrenia (68)
Series A (122)
Series B (73)
Service/supplier (11)
Sickle cell disease (54)
Southern California (1968)
Special edition (17)
Sponsored (29)
Startups (3762)
State (2)
Stomach cancer (13)
Supply chain (58)
The Weekly (42)
United States (20330)
Vaccines (653)
Venture capitalists (36)
Webinars (13)
Weight loss (239)
Women's health (32)
Worklife (15)
Date
Today (84)
Last 7 days (627)
Last 30 days (2951)
Last 365 days (35142)
2025 (6340)
2024 (36352)
2023 (41080)
2022 (52353)
2021 (56849)
2020 (55069)
2019 (47626)
2018 (35863)
2017 (33120)
2016 (32469)
2015 (38521)
2014 (32273)
2013 (27251)
2012 (29339)
2011 (29951)
2010 (28206)
Location
Africa (745)
Alabama (53)
Alaska (7)
Arizona (222)
Arkansas (13)
Asia (39102)
Australia (6515)
California (5258)
Canada (1796)
China (430)
Colorado (240)
Connecticut (260)
Delaware (118)
Europe (85524)
Florida (765)
Georgia (177)
Idaho (57)
Illinois (485)
India (22)
Indiana (282)
Iowa (8)
Japan (132)
Kansas (102)
Kentucky (24)
Louisiana (8)
Maine (60)
Maryland (811)
Massachusetts (4055)
Michigan (207)
Minnesota (356)
Mississippi (2)
Missouri (73)
Montana (29)
Nebraska (25)
Nevada (54)
New Hampshire (64)
New Jersey (1492)
New Mexico (29)
New York (1489)
North Carolina (947)
North Dakota (7)
Northern California (2275)
Ohio (183)
Oklahoma (13)
Oregon (36)
Pennsylvania (1180)
Puerto Rico (6)
Rhode Island (25)
South America (1119)
South Carolina (15)
South Dakota (1)
Southern California (1968)
Tennessee (85)
Texas (773)
Utah (158)
Virginia (124)
Washington D.C. (58)
Washington State (510)
West Virginia (3)
Wisconsin (45)
712,214 Results for "guided therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Guided Therapeutics Receives Order and Full Payment From Indonesia for 4 LuViva Systems and 1,200 Disposables
December 10, 2024
·
2 min read
Press Releases
Guided Therapeutics Announces Filing of Application for NMPA Approval to Market and Sell LuViva in China
October 23, 2024
·
4 min read
Career Advice
M&A Survival Guide: 6 Tips for Making the Most of a Stressful Situation
M&As are stressful for multiple reasons, including role changes and getting laid off when staffs combine. Two talent experts share tips for navigating the transition period of your company’s merger or acquisition.
January 23, 2025
·
6 min read
·
Angela Gabriel
Press Releases
Medigene and EpimAb Biotherapeutics Enter into a Co-Development Partnership for TCR-Guided T Cell Engagers
February 27, 2025
·
5 min read
Press Releases
Windtree Therapeutics, Inc. Announces Reverse Stock Split
February 19, 2025
·
7 min read
Press Releases
SkinCure Oncology Submits GentleBeam™ Image-Guided SRT for FDA Clearance
March 7, 2025
·
2 min read
Business
Money Meets Medicine: A Disruptor’s Guide to Life Sciences Investment
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis and Miruna Sasu, CEO of COTA, discuss life sciences investment and the potential for disruption.
February 27, 2025
·
1 min read
·
Lori Ellis
CRISPR
CRISPR
Ex Vivo
Gene Editing Gets on Target With Caribou’s Hybrid Guides
While
ex vivo
genome editing results in highly effective cell therapies, it can lead to off-target effects. Caribou Biosciences has come up with a novel approach for potentially more precise gene editing compared to all-RNA guides.
October 14, 2024
·
5 min read
·
Greg Slabodkin
Press Releases
Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
January 23, 2025
·
5 min read
1 of 71,222
Next
